Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-048922

SVP & Chief Scientific Officer bought 15,000 shares at $17.28 ($259,200)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2019-09-05 Purchase +15,000 $17.28 $259,200 107,668 D: show line 1 in the form
Open-market purchases · 15,000 sh · avg $17.28 · $259,200
Loading xslF345X03/doc4.xml…